News

Regeneron licensed a weight loss drug and revealed study data for a pair of muscle-preserving medicines. Elsewhere, two neuroscience biotechs cut deals and Bluebird officially went private.
Shahram Khaledi, CEO and owner of SK Group USA, reflected on his career in the business sector that has led to his success as ...
FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive ...
While the graphic logos of Duracell, Tiffany, or Corona may not immediately come to mind, the copper top, the robin’s egg ...
Investment firms The Carlyle Group Inc. (NASDAQ:CG) and SK Capital Partners, together with Beacon Parent Holdings, L.P., have successfully completed the tender offer for bluebird bio, Inc.
SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of ...
Campaigns like this allow companies like SK Life Sciences to reach a patient population directly. This allows the message to be tailored to the specific needs of the population. When it comes to ...